Image

Anterior Versus Posterior Surgery for Eyelid Ptosis

Anterior Versus Posterior Surgery for Eyelid Ptosis

Recruiting
All
Phase N/A

Powered by AI

Overview

The goal of this randomized clinical trial is to compare two surgical approaches for correcting drooping of the upper eyelid (aponeurotic ptosis) in adults who need surgery. This condition occurs when the tissue connecting the eyelid-lifting muscle to the eyelid becomes weakened or detached. It can affect one or both eyes.

The main questions this study aims to answer are:

  • Does surgery performed through the inner surface of the eyelid (posterior approach) achieve an upper eyelid height at 6 months that is not meaningfully worse than surgery performed through the skin (anterior approach)?
  • How do the two approaches compare in terms of complications, operating time, swelling, bruising, eyelid appearance, and patient satisfaction?
  • How stable are the results during the 6 months after surgery?

Researchers will compare anterior and posterior approaches to levator aponeurosis advancement, a procedure that repositions and reattaches the tissue connecting the eyelid-lifting muscle to the eyelid. Both approaches are routinely used at Hospital Universitario 12 de Octubre in Madrid, Spain, where the study will take place.

Participants will be assigned by chance to one of the two surgical groups, with an equal chance of receiving either approach. All procedures will be performed under local anesthesia by the same experienced surgeon.

The main outcome is upper eyelid height 6 months after surgery, measured as the distance between the upper eyelid edge and the reflection of a light at the center of the pupil. The study will assess whether the posterior approach is no more than 0.5 millimeters worse than the anterior approach for this measurement. An independent healthcare professional will measure eyelid height and assess eyelid appearance.

Participants will:

  • Attend a preoperative assessment, including an eye examination and measurements of eyelid position and movement.
  • Undergo surgery using the randomly assigned approach.
  • Attend follow-up visits the day after surgery, at 1 week, and at 1, 3, and 6 months.
  • Have eyelid measurements and standardized photographs taken, and be assessed for swelling, bruising, and complications.
  • Answer questions about their satisfaction with the appearance and function of their eyelids at 1, 3, and 6 months.

The visits and clinical assessments follow the hospital's usual care schedule for this surgery. Participation does not require additional visits or invasive tests beyond routine care.

Description

Scientific Rationale

Anterior and posterior approaches to levator aponeurosis advancement differ in the tissues accessed and the surgical exposure required to restore eyelid position. The anterior approach provides access through the skin and orbicularis muscle, whereas the posterior approach accesses the levator aponeurosis through the conjunctival surface. These differences may influence surgical duration, tissue trauma, postoperative recovery, and cosmetic results.

Although both approaches are established surgical options, direct prospective randomized comparisons remain limited. Evidence supporting posterior advancement includes surgical case series, while the anterior approach remains widely used. A randomized comparison may help clarify whether the posterior approach preserves functional effectiveness while offering advantages in recovery or other aspects of the surgical outcome.

Study Hypothesis and Methodological Rationale

The study uses a noninferiority framework for its primary efficacy comparison. This framework addresses whether posterior advancement maintains an acceptable functional result relative to anterior advancement, rather than requiring it to produce a greater postoperative eyelid height. Potential advantages in operative duration, postoperative tissue response, safety, and patient experience will be examined separately through secondary comparisons.

The allocation sequence will be computer-generated using randomly varying block sizes of four and six. A study team member who is not involved in performing the operations will generate the sequence. Variable block sizes are intended to maintain balance between groups during recruitment while reducing the predictability of subsequent assignments.

Using one surgeon experienced in both techniques is intended to limit variation attributable to differences in surgical experience. The surgeon cannot be masked to the assigned approach. An independent healthcare professional will perform the principal efficacy measurements and cosmetic assessments.

Statistical Analysis

Descriptive analyses will characterize the study population and summarize the data. Continuous variables will be reported as means and standard deviations or medians and interquartile ranges, as appropriate. Categorical variables will be reported as frequencies and percentages. The distribution of continuous variables will be assessed using the Shapiro-Wilk test.

The primary comparison will use analysis of covariance, with postoperative upper eyelid height at the primary assessment as the dependent variable, surgical approach as the group factor, and the corresponding preoperative measurement as a covariate. The treatment difference will be calculated as posterior minus anterior approach. Noninferiority will be established if the lower bound of the two-sided 95% confidence interval for the adjusted mean difference is greater than -0.5 mm. This corresponds to a one-sided significance level of 0.025.

Secondary continuous variables will be compared using an independent-samples Student's t-test or the Mann-Whitney U test, according to their distribution. Categorical variables will be compared using the chi-square test or Fisher's exact test, as appropriate. Changes in eyelid height over follow-up will be examined using repeated-measures analysis of variance or a linear mixed-effects model. Secondary comparisons will use a significance threshold of 0.05.

The primary noninferiority conclusion will be considered separately from the secondary comparisons. Demonstrating noninferiority in eyelid height alone will not be interpreted as evidence of superiority in safety, recovery, or cosmetic outcomes.

Eligibility

Inclusion Criteria:

  • Adults older than 18 years.
  • Diagnosis of unilateral or bilateral aponeurotic ptosis caused by weakening or disinsertion of the levator aponeurosis.
  • Clinical indication for surgical correction of ptosis.
  • No previous ocular surgery.
  • No other ophthalmic conditions that may affect eyelid anatomy.
  • Provision of written informed consent.

Exclusion Criteria:

  • Congenital, traumatic, neurogenic, myogenic, or mechanical ptosis.
  • Previous eyelid surgery.
  • Inability to provide informed consent or refusal to participate.
  • Inability to cooperate with the surgical procedure under local anesthesia because of cognitive impairment or another disabling condition.

Study details
    Ptosis
    Eyelid

NCT07936045

Hospital Universitario 12 de Octubre

14 November 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.